These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 7891889)
1. Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease. Hansen LA; Galasko D; Samuel W; Xia Y; Chen X; Saitoh T Neurosci Lett; 1994 Nov; 182(1):63-5. PubMed ID: 7891889 [TBL] [Abstract][Full Text] [Related]
2. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. Samuel W; Galasko D; Masliah E; Hansen LA J Neuropathol Exp Neurol; 1996 Jan; 55(1):44-52. PubMed ID: 8558171 [TBL] [Abstract][Full Text] [Related]
3. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. Hansen LA; Masliah E; Galasko D; Terry RD J Neuropathol Exp Neurol; 1993 Nov; 52(6):648-54. PubMed ID: 8229084 [TBL] [Abstract][Full Text] [Related]
4. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies. Hansen LA; Masliah E; Quijada-Fawcett S; Rexin D Neurosci Lett; 1991 Aug; 129(2):269-72. PubMed ID: 1745407 [TBL] [Abstract][Full Text] [Related]
5. The Lewy body variant of Alzheimer disease. Hansen LA J Neural Transm Suppl; 1997; 51():83-93. PubMed ID: 9470130 [TBL] [Abstract][Full Text] [Related]
6. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem. Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280 [TBL] [Abstract][Full Text] [Related]
7. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. Brown DF; Risser RC; Bigio EH; Tripp P; Stiegler A; Welch E; Eagan KP; Hladik CL; White CL J Neuropathol Exp Neurol; 1998 Oct; 57(10):955-60. PubMed ID: 9786245 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. Wakabayashi K; Kakita A; Hayashi S; Okuizumi K; Onodera O; Tanaka H; Ishikawa A; Tsuji S; Takahashi H Acta Neuropathol; 1998 May; 95(5):450-4. PubMed ID: 9600590 [TBL] [Abstract][Full Text] [Related]
9. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Olichney JM; Hansen LA; Galasko D; Saitoh T; Hofstetter CR; Katzman R; Thal LJ Neurology; 1996 Jul; 47(1):190-6. PubMed ID: 8710076 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Heyman A; Fillenbaum GG; Gearing M; Mirra SS; Welsh-Bohmer KA; Peterson B; Pieper C Neurology; 1999 Jun; 52(9):1839-44. PubMed ID: 10371532 [TBL] [Abstract][Full Text] [Related]
11. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P J Neural Transm (Vienna); 1996; 103(5):603-18. PubMed ID: 8811505 [TBL] [Abstract][Full Text] [Related]
12. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. Samuel W; Alford M; Hofstetter CR; Hansen L J Neuropathol Exp Neurol; 1997 May; 56(5):499-508. PubMed ID: 9143263 [TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Galasko D; Saitoh T; Xia Y; Thal LJ; Katzman R; Hill LR; Hansen L Neurology; 1994 Oct; 44(10):1950-1. PubMed ID: 7936253 [TBL] [Abstract][Full Text] [Related]
14. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Marui W; Iseki E; Kato M; Akatsu H; Kosaka K Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805 [TBL] [Abstract][Full Text] [Related]
15. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups. Gearing M; Lynn M; Mirra SS Arch Neurol; 1999 Feb; 56(2):203-8. PubMed ID: 10025425 [TBL] [Abstract][Full Text] [Related]
16. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Hansen LA; Samuel W Neurology; 1997 Jan; 48(1):126-32. PubMed ID: 9008507 [TBL] [Abstract][Full Text] [Related]
17. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients. Sparks DL; Scheff SW; Liu H; Landers T; Danner F; Coyne CM; Hunsaker JC J Neurol Sci; 1996 Jun; 138(1-2):97-104. PubMed ID: 8791246 [TBL] [Abstract][Full Text] [Related]
18. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study. Szpak GM; Lewandowska E; Lechowicz W; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Pasennik E; Kosno-Kruszewska E; Lipczyńska-Lojkowska W; Bochyńska A; Fiszer U Folia Neuropathol; 2001; 39(2):63-71. PubMed ID: 11680637 [TBL] [Abstract][Full Text] [Related]
19. Correlations between cortical and subcortical tau pathology. Attems J; Thomas A; Jellinger K Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520 [TBL] [Abstract][Full Text] [Related]